Outcome of the Board Meeting held on Wednesday, August 20, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Ganga Pharmaceuticals Ltd met on August 20, 2025 and approved several items. The 36th Annual General Meeting (AGM) of shareholders has been scheduled for Saturday, September 20, 2025. The Register of Members and Share Transfer Books will remain closed from September 14 to September 20, 2025 (both days inclusive) for the purpose of the AGM. The Board also approved the Directors' Report and Management Discussion and Analysis Report for the financial year ended March 31, 2025. Additionally, based on the Audit Committee's recommendation, M/s. D Maurya & Associates, a Mumbai-based firm of Practicing Company Secretaries, has been appointed as the Secretarial Auditor of the company for FY 2025-26.
This is a routine corporate governance update with no material impact on share price. Shareholders should note the book closure dates (September 14-20, 2025) as no share transfers will be processed during this period, and prepare for the AGM on September 20, 2025.